Kayluz Frias Boligan

Institution: Institute of Pharmacology/ University of Bern


Inselspital INO-F 3010 Bern Switzerland

Email: kayluz.frias@pki.unibe.ch

Group website: www.pki.unibe.ch/forschung/forschungsgruppen/gruppe_von_gunten/index_ger.html

Phone: 00316322522

Research interests:

Tumor Immunology, Breast Cancer, Glycobiology

Selected publications:

Schneider C, Smith DF, Cummings RD, Boligan KF, Hamilton RG, Bochner BS, Miescher S, Simon HU, Pashov A, Vassilev T, von Gunten S. The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites. Sci Transl Med. 2015 Jan 7;7(269):269ra1. doi: 10.1126/scitranslmed.3010524. Boligan KF, Mesa C, Fernandez LE, von Gunten S. (2014) Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense. Cell Mol Life Sci. Dec 7. Doi: 10.1007/s00018-014-1799-5 [Epub ahead of print] Jandus C*, Boligan KF*, Chijioke O, Liu H, Dahlhaus M, Démoulins T, Schneider C, Wehrli M, Hunger RE, Baerlocher GM, Simon HU, Romero P, Münz C, von Gunten S. (2014) Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest, Apr 1;124(4):1810-20. doi: 10.1172/JCI65899. *These authors contributed equally to this work Anghel SI, Correa-Rochal R, Budinska E, Boligan KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem GE, Fisher DE, Lévy F, Delorenzi M, Piguet V. (2012), Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF. Pigment Cell & Melanoma Research, 25: 482–487. doi: 10.1111/j.1755-148X.2012.01018.x

Members List